The Midwest's largest medtech event heads to the Twin Cities for its 23rd year November 8–9, 2017. Here are the happenings you won't want to miss.
News & Features
Data published this week could draw respect for and reduce skepticism over devices designed to lower the risk of stroke by closing a common heart defect.
Smiths Medical is scrambling to address cybersecurity risks involving its wireless infusion pump, a type of device that is particularly vulnerable to attack.
For the first time, the agency gives regulatory go-ahead to a mobile medical application system designed to treat patients with substance use disorders.
Some infusion sets may be vulnerable to a blockage that could cause too much insulin to be delivered to patients with diabetes, putting them at risk of hypoglycemia.
Advances in medtech aim to tackle chronic pain and combat the opioid epidemic that is spreading across the United States.
After weak sales, Abbott has decided to take its first-generation Absorb Bioresorbable Vascular Scaffold off the market. What’s next for the company’s bioresorbable technology?
With interest in outpatient surgeries continuing to increase, medical device companies should be asking themselves whether their products—as well as their customer support programs—are ready for such a shift. DePuy Synthes has been equipping ambulatory surgery centers with devices and support...
While regulatory agencies haven’t issued any official rules for medical device manufacturers to follow concerning connected devices, manufacturers should begin taking precautions.
In announcing its $42.9 billion inversion deal with Covidien two years ago, Medtronic vowed to use some of its new financial flexibility to invest $10 billion in U.S. medical technology over the coming decade.
We’re celebrating brilliant, budding minds in the medical technology field. These innovators, all under 30 years old, have racked up outsized achievements.